CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
批准号:
6687706
负责人:
MATTHEW Phillip HARDY
金额:
$33.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-01 至 2006-12-31
关键词:
Leydig cellsapoptosiscell cyclecorticosteroid receptorsendorphinsenzyme activitygene targetinggenetically modified animalsglucocorticoidshormone regulation /control mechanismhydroxysteroid dehydrogenasesintracellularlaboratory mouselaboratory ratluteinizing hormonenitric oxideoxidation reduction reactionphysiologic stressorprotein biosynthesisreceptor bindingreproductive developmentsteroid hormone biosynthesistestosteronetissue /cell culture
中文摘要
描述:(改编自申请人的摘要)Leydig细胞含有
糖皮质激素受体和响应糖皮质激素通过降低其速率
睾丸激素的分泌糖皮质激素的血清水平增加,
各种各样的条件引起的压力,包括疾病,运动和
心理社会互动根据这些事实,申请人和其他
研究人员假设男性生殖功能的下降
与压力有关的部分原因是Leydig细胞的直接抑制
糖皮质激素因此,申请人将检验以下假设:
在急性应激两小时内发生的睾丸激素下降,
不依赖于促黄体激素,并直接由糖皮质激素介导
作用于睾丸间质细胞他还将调查的生理作用,
11 β-羟基类固醇脱氢酶(11 β HSD),因为这种酶是
在Leydig细胞中大量表达并代谢糖皮质激素。三
提出了具体目标。目的(1)检测糖皮质激素的作用
通过Leydig细胞中的糖皮质激素受体(GR)介导,使用
肾上腺切除的大鼠和小鼠与间质细胞特异性敲除GR。
具体目标(2)将定义压力对Leydig细胞的影响。
目的(3)确定高剂量糖皮质激素的持续效应
暴露于应激后,
子宫内、围产期或成年期。这些研究将是第一个
确定GR介导的糖皮质激素对Leydig的直接作用程度
细胞在压力下其他应激诱导因子如一氧化氮和
将在睾丸水平监测β-内啡肽,因为它们可能影响
Leydig细胞功能独立和/或除了糖皮质激素。的
Leydig细胞中11 β HSD是应激的关键决定因素的假说
11 β氧化是一种常见的氧化模式,
成人Leydig细胞中的11 β HSD催化。反之亦然
未成熟的Leydig细胞,其中11 β-还原酶占主导地位。余额
氧化和还原催化活性显示的1型亚型的
Leydig细胞中的酶可以通过细胞内条件调节,
糖皮质激素效应的微调,受压力的影响。因此
申请人还将测试在细胞中内源性抑制剂的存在。
选择性调节11 β HSD的这些相反活性的睾丸。
预期的结果将表明,11 β HSD是一个关键的细胞内
睾丸间质细胞中睾酮生成的调节剂。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) Leydig cells contain
glucocorticoid receptors and respond to glucocorticoid by decreasing their rate
of testosterone production. Serum levels of glucocorticoid are increased during
stress caused by a wide variety of conditions, including disease, exercise and
psychosocial interaction. Based upon these facts, the applicant and other
investigators hypothesize that declines in male reproductive function
associated with stress are due in part to the direct inhibition of Leydig cells
by glucocorticoid. Therefore, the applicant will test the hypothesis that rapid
declines in testosterone occurring within two hours of acute stress are
independent of luteinizing hormone and are directly mediated by glucocorticoid
acting on Leydig cells. He will also investigate the physiological role of
11beta-hydroxysteroid dehydrogenase (11betaHSD) because this enzyme is
abundantly expressed in Leydig cells and metabolizes glucocorticoid. Three
Specific Aims are proposed. Aim (1) is to test for effects of glucocorticoid
mediated by glucocorticoid receptors (GR) in Leydig cells, using both
adrenalectomized rats and mice with a Leydig-cell-specific knockout of GR.
Specific Aim (2) will define the consequences of stress for the Leydig cell.
Aim (3) is intended to identify sustained effects of high glucocorticoid
concentrations on Leydig cell steroidogenesis after exposure to stress in
utero, perinatally or during adulthood. These studies would be the first to
establish the extent of direct, GR-mediated glucocorticoid action on Leydig
cells during stress. Other stress-induced factors such as nitric oxide and
beta-endorphin will be monitored at the testis level because they may affect
Leydig cell function independently and/or in addition to glucocorticoid. The
hypothesis that 11betaHSD in Leydig cells is a key determinant of stress
effects is supported by the fact that 11beta oxidation is the usual mode of
11betaHSD catalysis in Leydig cells from adults. The reverse is true of
immature Leydig cells where the 11beta-reductase predominates. The balance of
oxidative and reductive catalytic activity displayed by the type 1 isoform of
the enzyme in Leydig cells may be adjustable by intracellular conditions,
fine-tuning of glucocorticoid effects, affected by stress. Therefore, the
applicant will also test for the existence of endogenous inhibitors in the
testis that selectively modulate these opposing activities of 11betaHSD.
Anticipated results would show that 11betaHSD is a critical intracellular
regulator of testosterone production in Leydig cells.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Neutral endopeptidase is a myristoylated protein.
中性肽链内切酶是一种肉豆蔻酰化蛋白质。
DOI:
10.1007/s11010-009-0253-8
发表时间:
2010
期刊:
Molecular and cellular biochemistry
影响因子:
4.3
作者:
[Zheng,Rong, Horiguchi,Akio, Iida,Katsuyuki, Lee,Jungoo, Shen,Ruoqian, GoodmanJr,OscarB, Nanus,DavidM]
通讯作者:
Nanus,DavidM
Prenatal exposure to dexamethasone alters Leydig cell steroidogenic capacity in immature and adult rats.
产前接触地塞米松会改变未成熟和成年大鼠的 Leydig 细胞类固醇生成能力。
DOI:
10.1002/j.1939-4640.2001.tb03438.x
发表时间:
2001
期刊:
Journal of andrology.
影响因子:
--
作者:
[Page,KC, Sottas,CM, Hardy,MP]
通讯作者:
Hardy,MP
Inhibition of 11beta-hydroxysteroid dehydrogenase enzymatic activities by glycyrrhetinic acid in vivo supports direct glucocorticoid-mediated suppression of steroidogenesis in Leydig cells.
体内甘草次酸对 11β-羟基类固醇脱氢酶酶活性的抑制支持糖皮质激素介导的间质细胞中类固醇生成的直接抑制。
DOI:
10.2164/jandrol.107.004242
发表时间:
2008
期刊:
Journal of andrology
影响因子:
--
作者:
[Hu,Guo-Xin, Lin,Han, Sottas,ChantalM, Morris,DavidJ, Hardy,MatthewP, Ge,Ren-Shan]
通讯作者:
Ge,Ren-Shan
Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
肾上腺来源的 11β-羟基类固醇脱氢酶亚型 1 和 2 的内源选择性抑制剂。
DOI:
10.1016/j.mce.2005.08.006
发表时间:
2005
期刊:
Molecular and cellular endocrinology
影响因子:
4.1
作者:
[Latif,SyedA, Pardo,HectorA, Hardy,MatthewP, Morris,DavidJ]
通讯作者:
Morris,DavidJ
Protein kinase C increases 11beta-hydroxysteroid dehydrogenase oxidation and inhibits reduction in rat Leydig cells.
蛋白激酶 C 增加 11β-羟基类固醇脱氢酶氧化并抑制大鼠 Leydig 细胞的减少。
DOI:
10.1002/j.1939-4640.2002.tb02606.x
发表时间:
2002
期刊:
Journal of andrology
影响因子:
--
作者:
[Ge,Ren-Shan, Hardy,MatthewP]
通讯作者:
Hardy,MatthewP
共 12 条
18th North American Testis Workshop
-
批准号:6888448
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2005
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
ACTION OF ENDOCRINE DISRUPTORS ON THE LEYDIG CELL
-
批准号:6178198
-
项目类别:
-
资助金额:$29.37万
-
财政年份:1999
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
ACTION OF ENDOCRINE DISRUPTORS ON THE LEYDIG CELL
-
批准号:6382341
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1999
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
Action of an endocrine disruptor on the Leydig cell
-
批准号:6776280
-
项目类别:
-
资助金额:$29.31万
-
财政年份:1999
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
Action of an endocrine disruptor on the Leydig cell
-
批准号:7036598
-
项目类别:
-
资助金额:$28.62万
-
财政年份:1999
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
Action of an endocrine disruptor on the Leydig cell
-
批准号:7213368
-
项目类别:
-
资助金额:$23.27万
-
财政年份:1999
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
ACTION OF ENDOCRINE DISRUPTORS ON THE LEYDIG CELL
-
批准号:6073921
-
项目类别:
-
资助金额:$27.87万
-
财政年份:1999
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
Action of an endocrine disruptor on the Leydig cell
-
批准号:6883268
-
项目类别:
-
资助金额:$29.31万
-
财政年份:1999
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
GLUCOCORTICOID CONTROL OF LEYDIG CELL DEATH AND MITOSIS
-
批准号:6188751
-
项目类别:
-
资助金额:$3.92万
-
财政年份:1998
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
GLUCOCORTICOID CONTROL OF LEYDIG CELL DEATH AND MITOSIS
-
批准号:6017433
-
项目类别:
-
资助金额:$3.92万
-
财政年份:1998
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
GLUCOCORTICOID CONTROL OF LEYDIG CELL DEATH AND MITOSIS
-
批准号:2627559
-
项目类别:
-
资助金额:$3.14万
-
财政年份:1998
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:6260442
-
项目类别:
-
资助金额:$33.17万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:2403506
-
项目类别:
-
资助金额:$19.82万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:2206336
-
项目类别:
-
资助金额:$19.06万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:2673851
-
项目类别:
-
资助金额:$20.61万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:2889174
-
项目类别:
-
资助金额:$21.44万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:6627378
-
项目类别:
-
资助金额:$33.17万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:6490405
-
项目类别:
-
资助金额:$33.17万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
CORTICOSTEROIDS, STRESS AND LEYDIG CELL FUNCTION
-
批准号:6778870
-
项目类别:
-
资助金额:$5.75万
-
财政年份:1996
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
REGULATION OF LEYDIG CELL MITOSIS AND DIFFERENTIATION
-
批准号:2403473
-
项目类别:
-
资助金额:$10.89万
-
财政年份:1995
-
负责人:MATTHEW Phillip HARDY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: